Clinical Trial
Pulmonary Fibrosis, Interstitial Lung Disease Clinical Trial 2016-063
[LCID Study Number: 2016-063]
Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) and Chronic Fibrosing Interstitial Lung Disease With Progressive Phenotype Prospective Outcomes (IPF-PRO/ILD-PRO) Registry
The purpose of this study is to collect data and biological samples that will support future research studies.
Disease/Condition: Pulmonary Fibrosis, Interstitial Lung Disease
Department: Pulmonary and Critical Care
Location(s): Lahey Hospital & Medical Center (Burlington)
Primary Contact Email: Yuxiu.Lei@lahey.org